Biomarkers of aHSCT

Inclusion Criteria

• •1. Diagnosis of a immune mediated neurological disease according to disease specific criteria (active treatment arm) or diagnosis of relapsing remitting multiple sclerosis (control arm).
• •2. Treatment with autologous haematopoetic stem cell transplantation (active treatment arm) or high efficacy disease modifying treatment (control arm).
• •3. Willing to provide biological samples for analysis and undergo clinical assessments for the duration of follow up.
• •4. Able to understand English and provide informed consent.